Clinical and functional evaluation of patients with plantar fascıitis: A clinical study
KASAV INTERNATIONAL JOURNAL OF HEALTH SCIENCES · 2024
DOI: 10.29228/kijhs.87701 ↗Kurz gefasst
Fachartikel in der Zeitschrift KASAV INTERNATIONAL JOURNAL OF HEALTH SCIENCES, 2024. Verfasst von Ozgur Taspinar.
Abstract (Originalsprache)
BACKGROUND: Plantar fasciitis (PFs ) is the most common cause of heel pain. Although the prevalence of PFs is high, information on patho-anatomy of this disease in the literature is lacking. In our study, we aimed to understand the association of physical examination findings and radiological parameters with the disease in normal healthy people and in patient swith PFs. MATERIAL AND METHODS: Thirty consecutive patients with diagnosed PFs were included in the study. Thirty healthy volunteers consisted control group. Detailed physical examination was done. American Orthopedic Foot and Ankle Surgeons (AOFAS) scale was used to determine disability score. Body mass index (BMI) was calculated. Passive ankle and subtalar joints motion range was determined. Ultrasound was used for measuring thickness of plantar fascia. RESULTS: Mean age of patients with was 50.40±10.32 years. Mean age of healthy volunteers was 48.25±9.40 years. At the end of our study, ankle dorsiflexion and eversion angles, AOFAS scores were significantly lower in group of plantar fasciitis (p
Zitieren
APA
Taspinar, O. (2024). Clinical and functional evaluation of patients with plantar fascıitis: A clinical study. KASAV INTERNATIONAL JOURNAL OF HEALTH SCIENCES. https://doi.org/10.29228/kijhs.87701
Vancouver
Taspinar O. Clinical and functional evaluation of patients with plantar fascıitis: A clinical study. KASAV INTERNATIONAL JOURNAL OF HEALTH SCIENCES. 2024. doi:10.29228/kijhs.87701
BibTeX
@article{Taspinar2024,
author = {Taspinar, Ozgur},
title = {Clinical and functional evaluation of patients with plantar fascıitis: A clinical study},
journal = {KASAV INTERNATIONAL JOURNAL OF HEALTH SCIENCES},
year = {2024},
doi = {10.29228/kijhs.87701}
}
EUVIMED